Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $17,015 | 10 | 71.7% |
| Travel and Lodging | $2,694 | 15 | 11.3% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $1,750 | 3 | 7.4% |
| Food and Beverage | $975.02 | 17 | 4.1% |
| Education | $954.83 | 17 | 4.0% |
| Honoraria | $350.00 | 2 | 1.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Celgene Corporation | $9,938 | 13 | $0 (2019) |
| Pharmacyclics LLC, An AbbVie Company | $3,223 | 11 | $0 (2017) |
| AstraZeneca Pharmaceuticals LP | $2,300 | 1 | $0 (2019) |
| Exelixis Inc. | $2,050 | 4 | $0 (2019) |
| GlaxoSmithKline, LLC. | $1,950 | 1 | $0 (2020) |
| Janssen Scientific Affairs, LLC | $1,170 | 1 | $0 (2023) |
| Astellas Pharma US Inc | $599.99 | 2 | $0 (2021) |
| Amgen Inc. | $467.00 | 5 | $0 (2021) |
| Athenex Pharmaceutical Division, LLC | $350.00 | 2 | $0 (2020) |
| SANOFI-AVENTIS U.S. LLC | $312.90 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $416.33 | 3 | SOBI, INC ($200.00) |
| 2023 | $1,170 | 1 | Janssen Scientific Affairs, LLC ($1,170) |
| 2022 | $77.20 | 3 | PAINTEQ LLC ($45.40) |
| 2021 | $753.92 | 6 | Astellas Pharma US Inc ($500.00) |
| 2020 | $2,505 | 8 | GlaxoSmithKline, LLC. ($1,950) |
| 2019 | $15,014 | 27 | Celgene Corporation ($9,938) |
| 2018 | $270.00 | 2 | COMSORT, Inc ($150.00) |
| 2017 | $3,533 | 14 | Pharmacyclics LLC, An AbbVie Company ($3,223) |
All Payment Transactions
64 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/13/2024 | Curonix LLC | PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) | Food and Beverage | In-kind items and services | $78.92 | General |
| Category: PAIN MANAGEMENT | ||||||
| 09/19/2024 | SOBI, INC | VONJO (Drug) | Consulting Fee | Cash or cash equivalent | $200.00 | General |
| Category: HEMATOLOGY/ONCOLOGY | ||||||
| 05/14/2024 | Nalu Medical, Inc. | Nalu Neurostimulation System (Device) | Food and Beverage | In-kind items and services | $137.41 | General |
| Category: Pain Management | ||||||
| 05/23/2023 | Janssen Scientific Affairs, LLC | RYBREVANT (Drug) | Consulting Fee | Cash or cash equivalent | $1,170.00 | General |
| Category: Oncology | ||||||
| 11/16/2022 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $23.96 | General |
| Category: PAIN MANAGEMENT | ||||||
| 10/28/2022 | PAINTEQ LLC | PAINTEQ (Device) | Food and Beverage | In-kind items and services | $21.44 | General |
| Category: PAIN MANAGEMENT | ||||||
| 01/18/2022 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.80 | General |
| Category: ONCOLOGY | ||||||
| 12/07/2021 | Astellas Pharma US Inc | XOSPATA (Drug) | Consulting Fee | Cash or cash equivalent | $500.00 | General |
| Category: ONCOLOGY | ||||||
| 11/04/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $12.80 | General |
| Category: ONCOLOGY | ||||||
| 10/06/2021 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 06/01/2021 | Gilead Sciences, Inc. | — | Education | In-kind items and services | $11.92 | General |
| 03/08/2021 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 02/22/2021 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $31.20 | General |
| Category: ONCOLOGY | ||||||
| 11/23/2020 | Athenex Pharmaceutical Division, LLC | — | Honoraria | Cash or cash equivalent | $175.00 | General |
| 11/04/2020 | Athenex Pharmaceutical Division, LLC | — | Honoraria | Cash or cash equivalent | $175.00 | General |
| 08/20/2020 | Amgen Inc. | — | Education | In-kind items and services | $95.00 | General |
| 08/03/2020 | E.R. Squibb & Sons, L.L.C. | OPDIVO (Biological) | Education | Cash or cash equivalent | $11.75 | General |
| Category: Oncology | ||||||
| 05/22/2020 | GlaxoSmithKline, LLC. | — | Consulting Fee | Cash or cash equivalent | $1,950.00 | General |
| 02/12/2020 | PFIZER INC. | TALZENNA (Drug) | Education | In-kind items and services | $11.05 | General |
| Category: ONCOLOGY | ||||||
| 01/27/2020 | PFIZER INC. | IBRANCE (Drug) | Education | In-kind items and services | $11.96 | General |
| Category: ONCOLOGY | ||||||
| 01/10/2020 | Amgen Inc. | — | Education | In-kind items and services | $75.00 | General |
| 12/31/2019 | Exelixis Inc. | Cabometyx (Drug) | Travel and Lodging | Cash or cash equivalent | $18.00 | General |
| Category: Oncology | ||||||
| 12/12/2019 | Amgen Inc. | — | Education | In-kind items and services | $99.00 | General |
| 11/29/2019 | Exelixis Inc. | Cabometyx (Drug) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $1,480.00 | General |
| Category: Oncology | ||||||
| 11/24/2019 | AstraZeneca Pharmaceuticals LP | CALQUENCE (Drug) | Consulting Fee | Cash or cash equivalent | $2,300.00 | General |
| Category: Oncology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 3 | 186 | 257 | $27,083 | $19,769 |
| 2022 | 2 | 282 | 339 | $84,143 | $22,513 |
| 2021 | 2 | 482 | 761 | $180,918 | $60,446 |
| 2020 | 3 | 451 | 724 | $152,285 | $46,168 |
All Medicare Procedures & Services
10 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 163 | 234 | $23,184 | $16,862 | 72.7% |
| 99205 | New patient office or other outpatient visit, 60-74 minutes | Facility | 2023 | 11 | 11 | $2,123 | $1,613 | 76.0% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 12 | 12 | $1,776 | $1,295 | 72.9% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 223 | 279 | $61,730 | $16,761 | 27.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2022 | 59 | 60 | $22,413 | $5,752 | 25.7% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 371 | 649 | $139,042 | $48,309 | 34.7% |
| 99215 | Established patient outpatient visit, total time 40-54 minutes | Office | 2021 | 111 | 112 | $41,876 | $12,137 | 29.0% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 353 | 624 | $115,654 | $35,709 | 30.9% |
| 99215 | Established patient office or other outpatient, visit typically 40 minutes | Office | 2020 | 59 | 61 | $21,226 | $5,544 | 26.1% |
| 99205 | New patient office or other outpatient visit, typically 60 minutes | Office | 2020 | 39 | 39 | $15,405 | $4,915 | 31.9% |
About Dr. William Bonis, MD
Dr. William Bonis, MD is a Hematology & Oncology healthcare provider based in Chico, California. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 09/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1689779209.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. William Bonis, MD has received a total of $23,739 in payments from pharmaceutical and medical device companies, with $416.33 received in 2024. These payments were reported across 64 transactions from 24 companies. The most common payment nature is "Consulting Fee" ($17,015).
As a Medicare-enrolled provider, Bonis has provided services to 1,401 Medicare beneficiaries, totaling 2,081 services with total Medicare billing of $148,896. Data is available for 4 years (2020–2023), covering 10 distinct procedure/service records.
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Hematology & Oncology
- Location Chico, CA
- Active Since 09/14/2006
- Last Updated 03/13/2024
- Taxonomy Code 207RH0003X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1689779209
Products in Payments
- Pomalyst (Drug) $5,307
- BB-2121 (Drug) $4,631
- Imbruvica (Drug) $3,223
- CALQUENCE (Drug) $2,300
- Cabometyx (Drug) $2,050
- RYBREVANT (Drug) $1,170
- XOSPATA (Drug) $500.00
- ELITEK (Drug) $270.00
- KEYTRUDA (Biological) $250.00
- VONJO (Drug) $200.00
- Nalu Neurostimulation System (Device) $137.41
- JEVTANA (Drug) $99.95
- IBRANCE (Drug) $99.72
- DARZALEX (Drug) $98.74
- DRG IPGs (Device) $97.22
- BOTOX (Drug) $96.05
- VELCADE (Drug) $90.50
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A (Device) $78.92
- ZALTRAP (Drug) $62.95
- PAINTEQ (Device) $45.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Chico
Rubens Costa Filho, Md, MD
Hematology & Oncology — Payments: $26,473
Sufana Shikdar, Md, Mph, MD, MPH
Hematology & Oncology — Payments: $1,773
Yuan Ying, M.d,, M.D,
Hematology & Oncology — Payments: $1,550
Dr. Nicole Whitlatch, Md, MD
Hematology & Oncology — Payments: $574.29
Debra Garley, Md, MD
Hematology & Oncology — Payments: $561.21
Dr. John Hayward, Md, MD
Hematology & Oncology